Shares Magazine
9.43p+1.29 (+13.74%)25 Apr 2024, 16:34
Jump to:
C4X Discovery Holdings PLC Fundamentals
| Company Name | C4X Discovery Holdings PLC | Last Updated | 2024-04-25 |
|---|---|---|---|
| Industry | Biotechnology | Sector | Healthcare |
| Shares in Issue | 252.227 m | Market Cap | £27.04 m |
| PE Ratio | 2.25 | Dividend per Share | 0 |
| Dividend Yield | 0 | Dividend Cover | 0 |
| EPS | -£0.04 | EPS Growth (%) | 0 |
| PEG | 0 | DPS Growth (%) | 0 |
| Debt Ratio | 0.0098 | Debt Equity Ratio | 0.0002 |
| Asset Equity Ratio | 1.0658 | Cash Equity Ratio | 0.5335 |
| Quick Ratio | 13.8792 | Current Ratio | 15.31 |
| Price To Book Value | 0.9662 | ROCE | 0 |
C4X Discovery Holdings PLC Dividends
| Type | Ex-Date | Pay Date | Currency | Net Dividend | Year Total |
|---|
C4X Discovery Holdings PLC Company Financials
| Assets | 2023 | 2022 | 2021 |
|---|---|---|---|
| Tangible Assets | £441,000.00 | £754,000.00 | £410,000.00 |
| Intangible Assets | £1.25 m | £1.25 m | £1.26 m |
| Investments | 0 | 0 | 0 |
| Total Fixed Assets | £1.69 m | £2.01 m | £1.67 m |
| Stocks | 0 | 0 | 0 |
| Debtors | £38,000.00 | £2.52 m | £21,000.00 |
| Cash & Equivalents | £4.22 m | £5.08 m | £17.10 m |
| Other Assets | 0 | 0 | 0 |
| Total Assets | £8.78 m | £14.58 m | £21.40 m |
| Liabilities | 2023 | 2022 | 2021 |
|---|---|---|---|
| Creditors within 1 year | £2.17 m | £2.35 m | £1.86 m |
| Creditors after 1 year | £87,000.00 | £424,000.00 | £251,000.00 |
| Other Liabilities | 0 | 0 | 0 |
| Total Liabilities | £2.25 m | £2.78 m | £2.12 m |
| Net assets | £6.53 m | £11.80 m | £19.29 m |
| Equity | 2023 | 2022 | 2021 |
|---|---|---|---|
| Called up share capital | £4.54 m | £4.32 m | £4.30 m |
| Share Premium | £58.54 m | £53.35 m | £53.04 m |
| Profit / Loss | -£13.42 m | -£10.53 m | -£5.91 m |
| Other Equity | £6.53 m | £11.80 m | £19.29 m |
| Preference & Minorities | 0 | 0 | 0 |
| Total Capital Employed | £6.53 m | £11.80 m | £19.29 m |
| Ratios | 2023 | 2022 | 2021 |
|---|---|---|---|
| Debt Ratio | £0.01 | £0.03 | £0.01 |
| Debt-to-Equity | £0.01 | £0.04 | £0.01 |
| Assets / Equity | 1.0658 | 1.0658 | 1.0658 |
| Cash / Equity | 0.5335 | 0.5335 | 0.5335 |
| EPS | -£0.04 | -£0.04 | -£0.02 |
| Cash Flow | 2023 | 2022 | 2021 |
|---|---|---|---|
| Cash from operating activities | -£6.03 m | -£12.08 m | -£3.07 m |
| Cashflow before financing | -£942,000.00 | -£11.99 m | £11.47 m |
| Increase in Cash | -£938,000.00 | -£12.02 m | £11.46 m |
| Income | 2023 | 2022 | 2021 |
|---|---|---|---|
| Turnover | £1.71 m | £2.70 m | £5.64 m |
| Cost of sales | £38,000.00 | £130,000.00 | £90,000.00 |
| Gross Profit | £1.67 m | £2.57 m | £5.55 m |
| Operating Profit | -£13.41 m | -£10.52 m | -£5.89 m |
| Pre-Tax profit | -£13.42 m | -£10.53 m | -£5.91 m |
C4X Discovery Holdings PLC Company Background
| Sector | Healthcare |
|---|---|
| Activities | C4X Discovery Holdings PLC is a drug discovery and development company. It has various proprietary and synergistic software platforms Taxonomy3, Conformetrix, and 4Sight. Taxonomy3 is a novel in silico platform technology that utilizes proprietary ground-breaking mathematical algorithms to perform complex multivariate analysis of genetic data. Conformetrix enables rational, accelerated 4D structural drug design using experimental data rather than theoretical data. The 4Sightallows its research scientists to view, understand and interrogate the complex, multidimensional molecular shape data of drug molecules. |
| Latest Interim Date | 27 Mar 2024 |
| Latest Fiscal Year End Date | 14 Dec 2023 |
C4X Discovery Holdings PLC Directors
| Appointed | Name | Position |
|---|---|---|
| 2023-09-29 | Mr. Bradley Richard Hoy | Executive Director,Chief Financial Officer |
| 2023-12-15 | Dr. Alexander James Stevenson | Non-Executive Director |
| 2017-01-06 | Mr. Piers John Morgan | Executive Director,Chief Executive Officer |
| 2024-04-09 | Dr. Clive James Dix | Executive Director,Interim Chairman and Chief Executive Officer |
| 2022-12-23 | Mr. Harry Finch | Non-Executive Director |
| 2018-07-04 | Dr. Samuel Cameron Williams | Non-Executive Director,Chairman (Interim) |
| 2022-03-31 | Dr. Justian Craig Fox | Executive Director,Chief Scientific Officer |
| 2023-12-15 | Ms. Natalie Louise Walter | Non-Executive Director |
| 2023-09-29 | Ms. Bhavna Hunjan | Executive Director,Chief Business Officer |
C4X Discovery Holdings PLC Contact Details
| Company Name | C4X Discovery Holdings PLC |
|---|---|
| Address | 53 Portland Street, Manchester One, Manchester, M1 3LD |
| Telephone | +44 1612355085 |
| Website | https://www.c4xdiscovery.com |
C4X Discovery Holdings PLC Advisors
| Nominated Adviser | Panmure Gordon (UK) Ltd |
|---|---|
| Phone | +44 2078862500 |
| Stockbroker | Panmure Gordon (UK) Ltd |
|---|---|
| Phone | +44 2078862500 |
| Financial PR Adviser | Consilium Strategic Communications |
|---|---|
| Phone | +44 2037095700 |
| Solicitor | Schofield Sweeney LLP |
|---|---|
| Phone | +44 1132206270 |
| Fax | +44 1132439326 |
| Registrar | Capita Asset Services |
|---|---|
| Phone | +44 8716640300 |
| Fax | +44 2086392342 |
| Bank | Royal Bank of Scotland PLC |
|---|
| Auditor | KPMG |
|---|---|
| Phone | +44 1612464000 |
| Fax | +44 1612464040 |
Receive our
daily news email
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine
Plus more useful investment content and occasional promotional offers.
Market Overview
UK 350 Risers and Fallers
Risers
| Company | Price | % Chg |
|---|---|---|
| Anglo American PLC | 2,560.00 | 16.10 |
| Inchcape PLC | 786.00 | 9.32 |
| Barclays PLC | 204.00 | 6.73 |
| Astrazeneca PLC | 12,026.00 | 5.94 |
| Unilever PLC | 4,082.00 | 5.67 |
| Antofagasta PLC | 2,227.00 | 2.82 |
Fallers
| Company | Price | % Chg |
|---|---|---|
| Moonpig Group PLC | 155.00 | -12.73 |
| Trainline PLC | 302.00 | -11.95 |
| Indivior PLC | 1,400.00 | -7.53 |
| Auction Technology Group PLC | 493.00 | -6.98 |
| Legal & General Group PLC | 232.80 | -6.36 |
| Watches Of Switzerland Group PLC | 334.20 | -6.07 |